Recombinant epidermal growth factor (Shanghai Haohai )
外用重组人表皮生长因子（上海昊海）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant epidermal growth factor (Shanghai Haohai )
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2001/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Haohai Biological Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Haohai Biological Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A